Showing results (81-90 of 261) with videos related to
Sort By:
Pageof 27
The International Journal of Artificial Organs|January 1, 1980
Platelet function during haemoperfusion in acute liver failureR D Hughes, D A Lane, G Cella, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|June 25, 2013
Efficacy of adalimumab across subgroups of patients with moderate-to-severe chronic plaque psoriasis of the hands and/or feet: post hoc analysis of REACHY Poulin, J J Crowley, R G Langley, et al.Archives of Dermatology|February 20, 2008
Safety and efficacy of ABT-874, a fully human interleukin 12/23 monoclonal antibody, in the treatment of moderate to severe chronic plaque psoriasis: results of a randomized, placebo-controlled, phase 2 trialAlexa B Kimball, Kenneth B Gordon, Richard G Langley, et al.Clinical Science (London, England : 1979)|June 1, 1985
Fibrinogen derivatives and platelet activation products in acute and chronic liver diseaseR D Hughes, D A Lane, H Ireland, et al.European Journal of Clinical Investigation|October 1, 1977
Biocompatibility of coated and uncoated charcoal during haemoperfusion in healthy dogsM J Weston, A Hanid, M H Rubin, et al.Journal of the American Academy of Dermatology|August 18, 2020
Reduced risk of mortality associated with systemic psoriasis treatment in the Psoriasis Longitudinal Assessment and Registry (PSOLAR): A nested case-control analysisRichard G Langley, Yves Poulin, Bhaskar Srivastava, et al.The Journal of Dermatological Treatment|March 17, 2007
Adalimumab treatment is associated with improvement in health-related quality of life in psoriasis: patient-reported outcomes from a phase II randomized controlled trialRichard Shikiar, Michael Heffernan, Richard G Langley, et al.Journal of the American Academy of Dermatology|December 15, 2010
Efficacy and safety of ABT-874, a monoclonal anti-interleukin 12/23 antibody, for the treatment of chronic plaque psoriasis: 36-week observation/retreatment and 60-week open-label extension phases of a randomized phase II trialAlexa B Kimball, Kenneth B Gordon, Richard G Langley, et al.Dermatology and Therapy|January 29, 2021
Interleukin-17 and Interleukin-23: A Narrative Review of Mechanisms of Action in Psoriasis and Associated ComorbiditiesAlan Menter, Gerald G Krueger, So Yeon Paek, et al.Royal Society Open Science|August 16, 2018
Intra-individual variation in performance on novel variants of similar tasks influences single factor explanations of general cognitive processesJayden O van Horik, Ellis J G Langley, Mark A Whiteside, et al.Pageof 27